Clinical trials are at the heart of every advancement in treating cancer, yet lack of understanding about the benefits, risks and opportunities that trials offer can sometimes prevent patients from taking advantage of the newest drugs and treatments they make available.
Researchers in the UF Health Precision Cancer Care Program are identifying the genes of lung and colon cancer tumors, forming the first center in the state to perform this testing for solid tumors. By identifying particular gene mutations that drive cancers, physicians can deliver better, more targeted treatments to those cancers.
Each year, more than 1,000 patients take part in clinical trials at the UF Health Cancer Center. All are helping UF researchers chip away at the great unknown: what makes each person’s cancer tick, and how to stop that ticking without causing harm to the patient over the course of treatment.
UF Health cancer patients and their treatment teams rang the Liminal Bell, an art installation consisting of a bell created from an oxygen tank that is suspended from an oak beam structure. The word liminal is derived from the Latin word “limen,” which means “threshold.”